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Neuroprotection With Anesthetics in Two Models of Cerebral Ischemia

Rafael Eduardo Chaparro Buitrago, M.D.

ABSTRACT

Neuroprotection with anesthetics has been studied for many decades;
important advances in this field have modified the way Anesthesiologists treat
patients in the operating room. Animal models have played an important role in
the study of ischemia in the operating room. Recent studies have demonstrated
that the effect of anesthetics seems to be different in different animal models. We
decided to evaluate anesthetics in a well-known model of cerebral ischemia and
also in hypotensive models designed by us. We used a model of cerebral
ischemia (MCAO) to test anesthetics neuroprotective effect in a two-week period.
Then, we used a model of hypotension to characterize the damage caused by
this type of insult. Finally we characterized a model of hypotension plus hypoxia
that can mimic real situations in the OR.
We found that anesthetics alone do not have a neuroprotective effect after
two weeks in the MCAO model; but the combination of anesthetics with caspase
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inhibitors can decrease the damage caused by ischemia. The caspase inhibitor
by itself did not show a significant neuroprotective effect.
We also found that repetitive periods of profound hypotension can cause
important damage in the hippocampus but no memory or neurological changes
were seen. The induction of only one episode of hypotension plus hypoxia did
not alter the morphology of the hippocampus although induced memory changes
that were reverted by the use of anesthetics.
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INTRODUCTION:

Perioperative neuronal injury.
Neuronal injury during anesthesia although infrequent, can result in
subclinical neurocognitive deficit, long term disability or even death. The insult is
caused by ischemia or hypoxia. Recent implementation of different
neuroprotective maneuvers has reduced neurological morbidity and mortality.
Several surgical procedures are more likely to cause brain injury (1). For this
reason clinicians have been identifying these procedures and exploring possible
neuroprotective therapies for more than six decades (2).
Pathophysiology of Ischemic Cerebral Injury:
Ischemia is defined as a local or global and temporary deficiency of blood
supply, which may be accompanied by consequent cell alterations. In humans a
normal cerebral blood flow (CBF) is accepted as a blood flow between 45 to 50
ml/min/100g of tissue, which is usually generated by a mean arterial pressure
between 60 to 130 mmHg. If the CBF drops below 20 to 30 ml/min/100g of tissue
the cerebral cortex is considered ischemic.
Cerebral ischemia can be localized (focal ischemia) or generalized (global
ischemia). Macroscopically they have different characteristics but the
pathophysiology at the cellular level is similar. In focal ischemia the sudden loss
1

of cerebral blood flow causes immediate necrosis. This area is called “ischemic
core”. Around the core lies another region called the “ischemic penumbra”; in
this region there is a proliferation of apoptotic cells. If uncorrected the ischemic
damage will cause these cells to die in a few weeks increasing the size of the
infarct (3,4) as shown in Figure1.

Figure 1. Macroscopic pathology of focal Ischemia. Early in the course of
the lesion, the necrotic component (core) is the most important factor. Over
time, the penumbra area is responsible for the growth of the lesion (5).

Neurotransmitters are implicated in the pathogenesis of ischemic cell
injury, especially glutamate and GABA (6,7). After ischemia there is depletion in
2

energy stores. This depletion can lead to acidosis, failure of the Na+ / K+ pump
which produces membrane depolarization and/or an excessive release of
glutamate into the synaptic cleft. Glutamate activates N-methyl-d-aspartate
(NMDA) and α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)
receptors in the postsynaptic neuron. These receptors activate the voltage gated
calcium channels and in consequence there is an increase in the intracellular
calcium. High intracellular Ca++ levels produces activation of nitric oxide
synthetase (NOS), lipases, proteases and endonucleases. From here, two
pathways can be activated. First, apoptosis can lead to an irreversible cell
damage and cell death. The other pathway implicates NOS. Increased
production of nitric oxide (NO) and free radicals can lead to lipid peroxidation,
also causing irreversible cell damage and cell death. In some cases the ischemic
injury is not sustained and reperfusion occurs. When this happens, besides the
formation of free radicals, there is also inflammation with a subsequent cytokine
release and irreversible cell damage and cell death (4,8-10). These pathways are
depicted in Figure 2.

3

Figure 2. The neurodegenerative cascade (5). Ischemia leads to cell death
after cerebral ischemia through a series of intermediate steps.
In the penumbra area cells are mostly apoptotic. Apoptosis is defined as
programmed cell death in multicellular organisms. It is widely recognized that
there are three apoptotic pathways. Two are caspase dependent and one is
caspase independent. The first caspase dependent pathway is called the intrinsic
pathway, and is the mitochondrial mediated pathway. The second one is a
receptor mediated cascade and is called the extrinsic pathway (11).
The exact mechanism of activation on both pathways is not exactly
known, but the cascade after activation has been described. In the intrinsic
pathway cythochrome C is released from the mitochondria. Pro-apoptotic Bax
proteins induce cytochrome C release by opening the voltage dependent anion
4

channels (VDAC) allowing cytochrome C to pass through the channel. Bcl-2 and
Bcl-XL proteins have the exact opposite effect. They close the VDAC channels
and in this way prevent apoptosis. The cytochrome C activates procaspase 9 and
converts it to activated caspase 9. At this point the intrinsic and extrinsic pathway
merge into the common pathway and activate procaspase 3 converting it to
activated caspase 3. This caspase will cause cellular death (12,13). The extrinsic
pathway is a receptor mediated pathway. It is activated when the Fas receptor
(Fas-R) receives the Fas ligand (Fas-L). The Fas-R is a type two transmembrane
protein that is part of the tumor necrosis factor (TNF) family. The Fas associated
protein with death domain (FADD) is a molecule that serves as a bridge between
the Fas-R and the procaspase 8, converting it to activated caspase 8. After this
point the extrinsic pathway merges with the common pathway and activated
caspase 8 activates procaspase 3 resulting in apoptosis (14,15). The caspase
independent pathway is mediated by the apoptosis inducing factor (AIF) released
from the mitochondria. This factor induces apoptosis without using caspase
proteins (8).

5

Figure 3. Signaling pathway of ischemia induced apoptosis (8). Three
pathways culminating in apoptosis are depicted.

Hypotension.
Hypotension has been defined by the World Health Organization as a
systolic pressure below 110 mmHg in males and 100 mmHg in females. Diastolic
pressure is not taken into consideration (16). Chronic hypotension in humans is
responsible for a variety of symptoms like fatigue, dizziness, palpitations and
even cognitive alterations. Chronic hypotension does appear as damaging (17)
and there are autoregulatory mechanisms that protect specific organs against its
effects. Recent data suggests that hypotension is responsible for alterations in
cognitive performance (17,18). Some researchers have demonstrated that even
6

short periods of profound hypotension can cause cell damage in animal studies
(19).
During hemorrhagic hypotension, intravascular volume is lost and
regulatory mechanisms rapidly start compensatory mechanisms. The first event
occurs in the heart. Lack of volume causes a decrease in cardiac output. The
body reacts by decreasing the blood supply to organs with less oxygen
consumption like skin, intestines or muscle, while preferential flow is shifted to
the brain and the heart. Immediate vasoconstriction caused by local mediators
tends to stop bleeding and this mechanism is reinforced by an activation of the
sympathetic system that causes more vasoconstriction and also an increase in
cardiac output. When hypotension persists for long periods or when profound
hypotension is present these mechanisms are not sufficient to maintain cell
viability and the cells die by necrosis or apoptosis (20).
Cognitive dysfunction has been linked with hypotension(17,21), especially
in elderly patients(22-24). Several studies have studied the relation between
hypotension during surgery and neurological performance after surgery but so far
a clear link has not been found(25). The largest study that evaluated this point
was “The International Study of Postoperative Cognitive Dysfunction” but an
association between surgical blood pressure and postoperative cognitive
dysfunction was not found(26). In contrast, other researchers have found a clear
overall link between surgery and blood pressure during surgery (18,26,27).

7

Another important concept for the purpose of this presentation is hypoxia
reduction in O2 availability to tissue. This can be caused by a variety of
respiratory or circulatory factors.
There are direct and indirect measures to evaluate oxygen in the blood.
One of the indirect indexes is the pulse oximeter, a device that measures the
oxygen saturation. Normal ranges are from 95% to 100%, while values below
90% are considered hypoxic. A direct measurement can be made with arterial
blood gases analysis: which measures pO2 values. The normal range is between
80 to 100 mm Hg. During ischemia or hypotension, hypoxia is the main critical
factor since low levels of oxygen are responsible for cell injury. All living carbon
based organisms use oxygen for their metabolism. When cells do not receive
enough oxygen they enter in an inefficient anaerobic state and if this situation is
maintained for long periods they will die. After the hypoxic insult there is an
increase in intracellular calcium that can lead either to necrosis or apoptosis (28)
Anesthetics and neuroprotection with anesthetics.
Anesthetics have been shown to decrease ischemic/hypoxic cerebral
injury, but their action only last for short periods of time. This principle is correct
in some types of injury but not in others, so the purpose of this review is to study
the typical anesthetics and their actions in different models of cerebral
ischemia/hypoxia. There are two anesthetics that have been studied widely as
neuroprotective agents, propofol, an intravenous anesthetic and isoflurane, an
inhalational anesthetic.

8

Propofol (2,6-diisopropylphenol) is a nonbarbiturate intravenous general
anesthetic; Propofolcan be used alone with a continuous infusion or in
combination with inhalational anesthetics. Propofol can induce anesthesia more
rapidly than barbiturates and recovery is a lot faster and devoid of side effects. Its
mechanism of action is not well understood but the data suggests that propofol is
a GABAA receptor agonist and also has inhibitory action at the glutamate NMDA
subtype receptor. Propofol is also used to treat other pathologies like status
epilepticus, delirium tremens and refractory migraines; these uses are
considered a consequence of its glutamate antagonism or its GABA antagonism.
Propofol decreases intracranial pressure, decreases cerebral oxygen
consumption, increases cerebrovascular resistance and decreases cerebral
blood flow. In addition, propofol also has antiemetic properties by reducing
serotonin concentration in the dorso-lateral reticular formation. Also propofol has
been shown to attenuate neuronal injury (29).
The dosage used depends on the type of procedure, age of the patient or
the pathology that is being treated. For induction in adult neurosurgical patients,
slow administration is recommended using bolus of 20 mg every 10 seconds.
Slower boluses or infusion of propofol for induction of anesthesia, titrated to
clinical response, will generally result in reduced induction dosage requirements
(1 to 2 mg/kg). Maintenance dosage is 100 to 200 microgr/kg/minute (6 to 12
mg/kg/hour) IV (30).
Isoflurane is a general anesthetic, classified as halogenated anesthetic,
and is a nonflammable colorless liquid that requires a vaporizer for its clinical
9

use. Isoflurane provides a rapid induction and rapid recovery. It is also a muscle
relaxant, a very useful characteristic in the operating room. The mechanism of
action is unknown but some studies suggest that isoflurane can alter the
membrane function by decreasing the number of molecules that alternate
between gel and crystalline states (30). After inhalation, isoflurane is absorbed by
the pulmonary capillary system. It undergoes little biotransformation. Almost 95%
is exhaled unchanged, and only 0.17% is found in urine as metabolites. The
minimum alveolar concentration for an adult man is 1.15% but this decreases
with age. For induction in adults the recommended dose is 1.5 to 3%, which
induces, anesthesia in 5 to 10 minutes. Anesthesia maintenance in adults is 1.5
to 3.5% when inhaled in oxygen. In children 0.5 to 1.5% is the recommended
average dosage. For induction, the concentration of isoflurane should not be
higher than 3% and no more than 2.5%, in children (30).
Neuroprotection with anesthetics is a practice that has been used for
almost sixty years (1). The first anesthetics used for this purpose were the
barbiturates, and their neuroprotective activity was attributed to a reduction in the
metabolic rate. Research has shown that the anesthetics go even further and
have specific actions on specific receptors. The majority of anesthetics have an
antagonistic effect on the glutamate receptors (NMDA and AMPA). Some
researchers also believe that anesthetics can increase reuptake and decrease
the release of glutamate in the presynaptic neuron. Additionally, anesthetics have
an agonistic effect on GABAA receptors increasing itheir inhibitory activity. As a
result, a decrease in the intracellular Ca++ may block the deleterious effects of
10

ischemia/hypoxia (1,31-33). Bickler et al (2006); have demonstrated that
protection of hypoxic cortical neurons with anesthetics more specifically
isoflurane, involves signaling that includes changes in intracellular Ca++
regulation, several MAP kinase pathways and modulation of apoptosis regulators
(34).
There are also two pore domain potassium channels KC (K2P) that
provide regulation of membrane potential. These TREK channels are present in
the central nervous system and are activated by acidosis, temperature,
polyunsaturated fatty acids, membrane stretch and also by volatile anesthetics.
These channels have neuroprotective activity and their activation explains why
some polyunsaturated fatty acids have neuroprotective actions (35).
Brain relaxation is another one of the anesthetics’ properties useful in the
operating room. This is very important in neurosurgery, especially in patients with
intracranial hypertension caused by a reduced blood volume; relaxation is a
neuroprotective measure in this type of patients. Also propofol is known as a
drug that can reduce regional cerebral blood flow and metabolism, characteristics
that are also known as neuroprotective (36,37).
Anesthetics have been demonstrated to be protective only for two days
post-ischemia in cases of severe focal ischemia, but this effect was not
maintained at 14 days (38-40). This is probably due to the apoptotic activity in the
penumbra area (38). Anesthetics inhibit necrotic damage but are incapable of
reducing apoptotic injury (39). It is also important to mention that anesthetics
prevent necrotic injury only if they are administered during ischemia; they have
11

no action if administered after ischemia (41,42). Preconditioning with anesthetics
is another practice that has shown to be effective in reducing ischemic injury
(43).
Anesthetics also have neuroprotective action if the ischemic injury is mild
and although it does not produce necrosis, it can trigger apoptosis (44). If the
ischemic insult is mild, anesthetics by themselves are protective enough and can
decrease the neurologic morbidity (40). In the operating room, ischemic insults
vary from temporary vessel occlusion to profound systemic hypotension. In
general, insults tend to be temporal, mild and usually last for no more than 70
minutes. IT is generally accepted that ischemia lasting more than ten minutes
causes brain damage and it is also accepted that in the presence of anesthetics
this damage is substantially reduced (40).
Recent publications have shown that anesthetics can act as a necrosis
inhibitors and this action could buy some time to initiate therapies that modify
apoptosis. Some researchers have been studying apoptosis and antiapoptotic
therapies as a possible treatment for cerebral injury (45). Kawaguchi et al (2006);
used caspase inhibitors to prolong the neuroprotective effect of anesthetics in
models of middle cerebral artery occlusion with positive protective results (46).
However; unfortunately there are no proven antiapoptotic therapies available for
humans. Sakai et al (2007); reported long-lasting protection by Isoflurane with no
need for the use of caspase inhibitors (48) and provided good evidence that the
difference with Kawaguchi et al (2004) was caused to the later using an MCAO
model that integrated permanent carotid occlusion and thus persistent
12

hypoperfusion (38). On the other hand, Elsersy et al (2004) showed evidence of
decline of the protective effect of Isoflurane over time; suggesting that the
protection between local and global ischemia is different (47);.
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Abstract:
Introduction:
Neuroprotection researchers have used caspase inhibitors to reduce
neuronal damage caused by ischemia. Most of the trials have shown positive
effects when these substances were administered intracranially (1).
There is very limited evidence that caspase blockers can be used systemically
and still have a beneficial effect. We hypothesized that caspase inhibitors could
cross the hematoencephalic barrier during ischemic events like stroke.

Materials and methods:
To test our hypothesis we used 250 to 350g male Sprague Dawley rats of
an average age of three months examined after MCAO+CCAO. The control
group (group 1) received no treatment following the surgery (n=10). Group 2
received 90 minutes of 1% Isoflurane while inside an exposure chamber (n=7).
Group 3 received 35 mg/kg/h of Propofoli.v. for 90 minutes (n=7). Group 4
received the 1% Isoflurane treatment for 90 minutes followed by 3 systemic
injections of a caspase 3 inhibitor (100 µg Z-DEVD-FMK, BD Pharmingen, San
Jose, CA) that were given 3 times: immediately after, 24 hours after and one
week after Isoflurane treatment (n=7). Group 5 received 35 mg/kg/h of
Propofolfor 90 minutes followed by the same caspase 3 inhibitor treatment
regimen as group 4 (n=6). Group 6 received only Caspase 3 inhibitor as
described before (n=6). Neuroscore evaluation was made on days 0, 4 and 14.
Animals were euthanized two weeks after MCAO+CCAO. Brains were harvested,
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sectioned, and a series of adjacent sections were stained for H&E, TUNEL and
cleaved caspase-3. Infarct size as a percentage of the normal hemisphere was
reported. The numbers of positively stained neurons were counted within the
infarcted hemisphere using unbiased Stereology (Stereology Resource Center,
Chester, MD). Statistical analysis was performed using Graphpad Prism 5 with
Bonferroni test at a 95% confidence interval, after ANOVA (* p<0.05).

Results:
The combination of Isoflurane plus a caspase 3 inhibitor significantly
reduces the infarct size two weeks after the infarct; the rest of the groups did not
show a statistically significant difference. The number of neurons that were
positive for TUNEL were not significantly different in the groups that were treated
with Propofoland Isoflurane alone compared to the control group. However, the
number of positive TUNEL neurons were significantly lower in animals that
received Z-DEVD-FMK in comparison with the animals that did not received the
caspase inhibitor. These results were confirmed with the significant reduction in
cleaved caspase 3 positive neurons in the groups treated with the caspase
inhibitors compared to the control group and the rats treated with anesthetics
alone.
Conclusion:
Isoflurane plus systemic administration of caspase 3 inhibitor has a
positive effect in the histological outcome of ischemic brains. With the significant
reduction in apoptotic cells, we demonstrated that the caspase inhibitor can
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reach intracerebral targets after intraperitoneal injections and block the apoptotic
cascade, decreasing the deleterious effects of programmed cell death.
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Introduction:
Neuronal injury during anesthesia although infrequent, can result in
subclinical neurocognitive deficit, long-term disability or even death, being the
insult usually due to ischemia, hypoxia or both. Innovative neuroprotective
maneuvers have shown to decrease neurological morbidity and mortality. Some
surgical procedures are more likely to cause brain injury (2), for this reason
clinicians have been identifying these procedures and working in possible
neuroprotective therapies for more than six decades (3). Researches have
demonstrated that anesthetics can decrease the ischemic damage, in some
cases the neuroprotective effect was only evident for short periods of time (4), in
contrast; other researchers have found positive effects up to 8 weeks after the
insult (5). Sakai et al; evaluated the effect of anesthetics in different models of
ischemia and found that the effect of anesthetics can change depending on the
model used to test the neuroprotective effect of the drugs (4,5). Independently of
the model used, the histological damage increases day after day for extended
periods of time and these changes can be divided in two stages: an early stage
and late stage. Early changes are related to acute neuronal death mediated by
glutamate activity and neuronal depolarization; and anesthetics like isoflurane
have shown to be effective in blocking glutamate activity and neuronal
depolarization (6-9). Delayed damage is caused mainly by apoptosis; however,
other factors like inflammation play an important role. Researchers have used
caspase inhibitors to block the apoptotic cascade with remarkable success (1,1012).
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Researchers do not agree in how to manage the ischemic injury but in
general there is an agreement that no single therapy is sufficient (13). We
consider that the combination of an anesthetic plus caspase inhibitors can
reduce brain damage compared with each therapy used alone.
Materials and Methods.
Regulations:
The present study was presented, evaluated and approved by the division
of Comparative Medicine at the University of South Florida (USF). The
experiments were done in following the guidelines of the IACUC of the University
of South Florida’s College of Medicine.

Table 1. Study design Z-DEVD-FMK caspase 3 inhibitor from Biosciences
pharmaceutical. IV = intravenus. DMSO: Dimethyl Sulfoxide.
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The animals were divided in 6 groups as shown in table 1a. Animals were
treated with anesthetics alone or in combination with caspase 3 inhibitors. A
group was treated only with the caspase inhibitor and all groups were compared
with the controls.
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Table 2. Time course.The project was designed to evaluate the
neuroprotective effect of anesthetics alone or in combination with caspase
inhibitors in a 2 week period.
Table 2 shows the specific order of occurrence of the events. Day 0 is the day of
the surgery.

Animals:
Male Sprague Dawley rats from Harlan Laboratories (Indianapolis, IN),
with ages between 60 to 90 days and weights between 250 to 350 grams were
used for this experiment. Upon arrival to the USF College of Medicine Vivarium
the rats were housed in a climate controlled room in plastic cages in groups of
two with free access to water and food and were left in quarantine for a week
before the experiment took place. In general, all animals received the same
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anesthesia for the vascular occlusion surgery (see description below). In addition
the animals were divided in 6 groups:
1. Control group, these animals received a Middle Cerebral Artery
occlusion plus Common Carotid Artery Occlusion (MCAO + CCAO) with no
treatment.
2. Isoflurane group received 90 minutes of 1% Isoflurane and 100%
Oxygen in a sealed chamber after the surgery.
3. Propofol group received 90 minutes of Propofolintravenously (tail vein)
at 35mg/kg/h after the surgery.
4. Isoflurane plus caspase 3 inhibitor (C3I) group: received Isoflurane 1%
and 100% Oxygen in a sealed chamber for 90 minutes after the surgery and C3I
intraperitoneal100µg in Dimethyl sulfoxide (DMSO) 0.1ml. The caspase 3
inhibitor used was Z-DEVD-FMK from DB Pharmingen (San Jose CA.), the
animals were injected 3 times: immediately after the surgery, the next day after
the surgery and a week after the surgery.
5. Propofol plus C3I; received 90 minutes of Propofolintravenously (tail
vein catheter) at 35mg/kg/h after the surgery plus C3I intraperitoneal100µg in
(DMSO) 0.1ml intraperitoneal 3 times: immediately after the surgery, the next
day after the surgery and a week after the surgery.
6. C3I only, this group received the caspase 3 inhibitor after surgery with
the same dosage and schedule as the other groups.
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Neurological Assessment:
We used a seven point neurological score to evaluate the animals (Table
2) (1). The test was done at four different time points. The first evaluation was the
day before the surgery. This test was performed to assure that neurologically the
rats were intact. No animals were withdrawn from the study for failing this
evaluation.
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Table 3. Neurological score. All animals were evaluated before the surgery,
at day one after the surgery and two weeks after the surgery (1).

The neurological evaluation was done in all the groups: one day after the
surgery, four days after the surgery and fourteen days after the surgery. Dead
animals were not included in the neurological score; mortality information was
recorded and is presented in the results section.
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Anesthesia:
After the weight was recorded, the animal was anesthetized in an
induction chamber with 5% Isoflurane in 100% Oxygen. After the rat was fully
anesthetized we changed the animal from the induction chamber to a mask with
1 to 2% Isoflurane in 100% oxygen.
Doppler Study:
After shaving the head and neck, the animal was placed in a stereotactic
frame. A sagittal incision was made to expose the skull; all the connective tissue
was removed with a cotton applicator until the bregma was fully identified. A
Dremel 400 Series XPR rotary tool was attached to the frame to precisely
microdrill a hole at 1 mm posterior and 4 mm lateral to the bregma in the same
hemisphere were the middle cerebral artery occlusion plus common carotid
artery occlusion occurred. An intracerebral guide cannula from Harvard
Biosciences Company was inserted in the hole and was sealed in place with
dental cement; a Laser Doppler optic rigid prove (500µm) attached to a Laser
Doppler monitor from Moor Instrumets LTD, was inserted into the guide cannula.
The intracerebral blood pressure was then recorded using Laser Doppler,
Windows compatible software from Moor Laboratories previously installed in a
Dell computer.
The animal was then taken off the stereotactic frame and placed on a
custom made stainless steal surgical board from Calven de Oriente C.A. During
the surgery we were looking for a sharp decrease in blood flow, the animals that
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did not reach al least 50% decrease in blood flow were not included in the study.
An average of 77% decrease in blood flow was recorded in the animals after the
arterial occlusion. After the surgery, probe and cannula were removed and the
skin sutured with a skin stapler. After the surgery the animal was placed in a
fresh cage for recovery.
Permanent Middle Cerebral Artery Occlusion plus Common Carotid Artery
Occlusion:
A medial incision on the middle line of the neck was done with a 15 blade
scalpel, the common carotid, external carotid and internal carotid arteries were
identified, and permanent ligation of the common carotid artery with a 4-0 silk
was followed by an incision in the arterial bifurcation of the common carotid
artery. A 4 cm Ethicon 4-0 Prolene monofilament was inserted trough the arterial
incision into the internal carotid artery and advanced until the middle cerebral
artery was reached and resistance was felt. The tread was secured in place with
a 4-0 silk. The skin was closed with a skin stapler (14).
Physiological parameters:
We measured physiological parameters to assure that the results we
obtained were due to the treatment and could not be confused with alterations in
physiologic changes. The variables we measured were: Weight, temperature
taken with a rectal thermometer (a heated pad was used to maintain body
temperature during the procedure); a pulse oximeter was used to measure
hemoglobin saturation (Hb Sat); heart rate (HR) and blood pressure (BP) were
taken directly from an arterial catheter placed on the femoral artery (SurgiVet
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Advisor Monitor. Model number 92V303100 was used for Hb Sat, HR and BP);
hematocrit was measured using Damon IEC MB Micro Hematocrit Desk-Top Lab
Centrifuge. The measurements were taken before and after the ischemic event.
Weight was measured right before the surgery and at day 14.
Brain Collection and Sectioning
The animals were euthanatized with an overdose of CO2; immediately
after, the animal was perfused with normal saline solution 0.9% followed by 4%
paraformaldehyde. The brains were harvested, stored in plastic tubes with 4%
paraformaldehyde for 24 hours, and then changed to 10%, 20% and 30%
sucrose every 24 hours. After that, brains were sectioned with a cryostat at
50µm; sections were collected as soon as the infarct area appeared and two of
every 5 sections were collected for TUNEL and Cleaved Capase 3 staining until
the infarct area was no longer visible (15). A total of 5 to12 sections per brain
were collected depending on the infarct size. Sections were stored in PBS plus
Azide and then mounted for histopathology analysis.
Hematoxylin and Eosin staining:
H and E analysis was used to quantify the infarct size; the staining method
used consisted in: 2 changes in absolute ethyl alcohol for 1 minute. Then, 2
changes in 95% ethyl alcohol for 1 minute and wash in running tap water for 1-2
minutes. Sections were immersed in Mayer's hematoxylin, for 5-10 minutes and
then washed in running tap water for 10 minutes. Later submerged in working
Eosin-Phloxine for 2-3 minutes. 2 more changes in 95% ethyl alcohol for 2
minutes each with gentle agitation at each change. After that absolute ethyl
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alcohol for 2 minutes. Clean in 3 changes of Xylene of 2 minutes each. Finally,
coverslip directly from xylene (16).
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)
staining:
TUNEL was used to evaluate the effect of Z-DEVD-FMK, Caspase 3
Inhibitor in the infracted hemisphere. ApopTag In Situ Apoptosis Detection Kit
from Chemicon International, Temecula, CA., CAT. #: S7100-KIT was used
following the instructions of the supplier.
Cleaved Caspase 3 Staining:
We used Cleaved caspase 3 positive cells to confirm that the Z-DEVDFMK injected intraperitonely reach specific targets in the brain.
Permeabilize in ethanol/acetic acid, 2:1. Wash in 2 changes of PBS. Mounted
slides were hydrated in graded ETOH washes to deionized water (5 minutes
each). Antigen retrieval was performed using the heating method; sections were
steamed in 0.1M citrate buffer, pH 6.0, for 25 minutes, and cooled for 20 minutes.
The tissues were washed in PBS for 10 minutes, followed by quenching of
endogenous peroxidase activity with 3% H2O2 wash for 10 minutes. The tissues
were washed in PBS (3 x 5 minutes each) followed by a blockade of nonspecific
protein binding with 10% normal goat serum, 2% BSA, PBS for 30 minutes at
room temperature. The tissues were incubated in avidin for 15 minutes, followed
by biotin for 15 minutes, and then incubated at Negative controls were incubated
without the primary antibody. Following a PBS wash (4 x 5 minutes), the tissues
were incubated with the secondary antibody (biotinylated anti-rabbit IgG) at
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room temperature for 30 minutes. Following a PBS wash (4 x 5 minutes each),
the tissues were incubated with Vector ABC (elite Kit) for 20 minutes at room
temperature. Following a final PBS wash (4 x 5 minutes each), the sections were
incubated in a DAB substrate for visualization of the peroxidase-reaction. The
sections were washed in deionized water (5 minutes), counterstained, and
dehydrated (graded ETOH, 5 minutes each step). Sections were then washed in
xylene (3 x 5 minutes each) and coverslipped with permount.(15)
Statistical Analysis:
The data are presented as Mean ± SE. To measure the infarct size and
count the number of TUNEL and Cleaved Caspase 3 positive cells we used
unbiased stereology (17) (Cavalieri estimator and optical dissector respectively)
measured with the Stereologer from Stereology Resource Center, Chester,
Maryland. We evaluated the volume of the infarct and also the volume of the
opposite hemisphere; results are presented as a stroke area as percentage of
the area of the opposite hemisphere to compensate for edema. The results were
analyzed using GraphPad Prism 5.0 for Mac. Analysis of Variance was follow by
Fisher LSD formula.
To quantify the number of TUNEL and Cleaved Caspase 3 positive cells in
the infracted hemisphere we used unbiased stereology (Optical fractionator), the
results are an estimate of the total number of cells. The results were analyzed
using GraphPad Prism 5.0 for Mac. 1 way Analysis of Variance was follow by
Bonferroni’s Multiple Comparison Test. p-value of <0.05 were considered
statistically significant.
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Results
We designed the experiment with 70 animals; 6 of them (1 animal per
group), were excluded because the Doppler never showed a sharp decrease in
blood flow (at least 60% decrease). We believe that either the intra-arterial tread
or the Doppler were misplaced. 9 more animals died during the surgery from
subarachnoid hemorrhage, bleeding from the arterial incision and other technical
issues; this include 3 animals in the control group, 1 animal in the Isoflurane
group, 2 animals in the Isoflurane plus caspase 3 inhbitor, 2 animals in the
propofol plus caspase 3 inhibitor and 1 in the caspase 3 group. 12 animals died
or were euthanized due to neurological dysfunction between the day of the
surgery and day 14; this included 6 animals in the control group, 1 in the
Isoflurane group, 2 rats in the propofol group, 1 in the propofol plus caspase 3
inhibitor group and 2 in the caspase 3 inhibitor group. No replacement animals
were added to the study.
As previously described several physiological variables were considered.
We evaluated rectal temperature, mean arterial pressure (MAP), heart rate (HR),
hemoglobin saturation (Hg-Sat), and hematocrit. The results are shown in the
table below. We did not find any statistically significant differences between the
pre-operative values and the post-operative values. We also did not find
statistically significant changes in the initial and final weight measured before the
ischemic event and at day 14. Physiological variables are shown on Table 4.
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Table 4. Physiological Variables. Values are mean ± SD. MAP = Mean
Arterial Blood Pressure, HR = Heart rate, T0 = Temperature, C3I = Caspase
3 inhibitor, MCAO = Middle Cerebral Artery Occlusion, BPM = Beats Per
Minute, Hb = Hemoglobin.

Neurofunction index was calculated in the animals as shown in the next
figure (Neurological Scores) (1). Behavior measurements on postoperative day 4
demonstrated a reduction of impairment in both groups receiving the caspase
inhibitor ( p < 0.05). This trend is voided by day 14, when all animals approached
baseline scores. The test used for this purpose was an eight point neurological
score (from 0 to 7) the animals that score 0 were perfectly normal and the
damage progress until a score of 7 when the animal is dead. This score only
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measures motor behavior; it does not include the sensory system, memory or
any other abilities.

6
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Figure 1. Neurological Performance. Behavior measurements on
postoperative day 4 demonstrated a reduction of impairment in both
groups receiving the caspase inhibitor. This trend is voided by day 14,
when all animals approached baseline scores.
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We used Stereology (Cavalieri Method) (17) to accurately measure infarct
volume. To compensate for edema, we compared the ipsilateral infarcted area with
the contra lateral hemisphere area. Significant differences in infarct volume were
observed. The groups treated with anesthetics alone (Isoflurane and Propofol)
showed no significant differences in infarct size compared to the control group.
However, the addition of caspase 3 inhibitors to Isoflurane resulted in up to 50%
reductions in infarct size 14 days after permanent focal cerebral ischemia ( p <
0.05 ). See Figure 2.
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Figure 2. Relative infarct area to compensate for edema. The graph shows
the quantification of the average volume of infarct size 14 days after
permanent focal cerebral ischemia as determined by stereological analysis
of H&E histochemistry. C3I (Caspase 3 Inhibitor)
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Infarct volumes are shown in the figure, photomicrographs of brain sections
were taken from MCAO rats in all groups. Total infarct volume including cortical
and subcortical structures were measured. The only group that showed a
statistical significant difference was the group treated with Isoflurane plus the
caspase 3 inhibitor ( p < 0.05 ).

Figure 3. Microphotographs of the infarcts at day 14 after the injury.
Isoflurane plus caspase 3 inhibitor reduce the infarct size in Sprague
Dawley rats 14 days after stroke. C3I = Caspase 3 Inhibitor.
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Neither propofol nor isoflurane alone showed any statistically
demonstrable benefit after 14 days. Interestingly, the combination of propofol
plus the caspase inhibitor and the caspase inhibitor by itself did not show a
demonstrable benefit. Thus, elevations in caspases that follow focal ischemia
appear to contribute to the ischemic injury and are critical targets to reduce
infarct size only in combination with isoflurane for this particular ischemic model.
The number of neurons that were positive for TUNEL two weeks after
permanent occlusion of the middle cerebral artery plus common carotid artery
occlusion, were not significantly different in the groups that were treated with
propofol and Isoflurane alone compared to the control group. However, the
number of positive TUNEL neurons were significantly lower in animals that
received the caspase 3 inhibitor in comparison to the animals that did not.
(p < 0.05 for the three groups).
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Figure 4. Estimated total number of TUNEL positive cells in the stroke
hemisphere. The number of TUNEL positive cells is lower in the animals
that received the C3I ( Caspase 3 Inhibitor ).

These results were confirmed with the significant reduction in cleaved
caspase 3 positive cells in the groups treated with the caspase 3 inhibitor
compared to the control group and with the rats treated with anesthetics alone
(p< 0.05 for the three groups).
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Figure 5. Estimated total number of cleaved Caspase 3 positive cells in the
stroked hemisphere. The number of cleaved caspase 3 positive cells is
significantly lower in the animals treated with C3I ( Caspase 3 Inhibitor ).

Discussion:
The results suggest that the intraperitoneal injection of Z-DEVD-FMK,
caspase 3 inhibitor in combination with isoflurane has a neuroprotective effect in
a model of permanent cerebral ischemia two weeks after the initial injury.
It is important to mention that the volume size of the Z-DEVD-FMK group is
statistically significant when the statistical analysis is done using Anova followed
by Bonferroni test but it disappeared when we used Fisher LSD as post-test. We
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decided to publish only the Fisher LSD results because it is the most widely used
test in ischemia research.
At day four the neurological score only showed significance in the groups
that received the combination, this is another reason to consider that the caspase
3 inhibitor by it self does not have a neuroprotective effect in this model of
permanent ischemia. The neurological findings were correlated with the
histological findings, showing that the combination of Z-DEVD-FMK, caspase 3
inhibitor and isoflurane is indeed neuroprotective. Isoflurane or propofol are not
neuroprotective when administered alone in this model of permanent ischemia
two weeks after the insult.
Although apoptosis plays an important role after ischemia and blocking it
seems to be the right answer; we have demonstrated that apoptosis is not the
only answer in neuroprotection, it is also important to block the necrosis and
anesthetics have demonstrated to be useful in this area (5). In previous studies,
researchers have used intracerebral injections of caspase inhibitors (11,18), in
this study we used intraperitoneal injections of a caspase 3 inhibitors, we believe
that since the hematoencephalic barrier is broken after a stroke that facilitates
the entrance of the caspase inhibitor. We measured the number of apoptotic cells
in the infarcted hemisphere and we found a significant decrease in the TUNEL
positive cells in all the groups that received the caspase inhibitor. We also
counted the number of cleaved caspase 3 positive cells in the infarcted
hemisphere to confirm the results found in the TUNEL analysis and the results
were similar.
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Since not all the groups that received the caspase inhibitor showed a
significant decrease in infarct size we conclude that Isoflurane plays an important
role as neuroprotective agent. We used a model of permanent cerebral ischemia,
the presence of the surgical treat in the arterial side causes a continuous local
reaction leading to apoptosis, and this is one of the factors that may explain the
positive effect of caspase inhibitors in this model.
In this study we corroborate that in a model of MCAO plus CCAO the
addition of caspase inhibitors is necessary to achieve neuroprotection that
anesthetics alone do not offer. The differences found with results reported by
Sakai et al; (5) could be justified by the fact that we created permanent global
ischemia since we permanently occluded the common carotid artery. Sakai
reported persistent protection from Isoflurane with no need for the use of a
caspase inhibitor and provided good evidence that the difference with Kawaguchi
et al; (12) was due to the later using an MCAO model that integrated permanent
carotid occlusion and thus persistent hypoperfusion. On the other hand, Elsersy
et al; (19) showed evidence of decline of the protective effect of Isoflurane over
time; suggesting that the protection between local and global ischemia is
different. It seems clear now that volatile anesthetics have a neuroprotective
action under specific conditions (mild to moderate severity) (20).
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Abstract:

Introduction:
Maintenance of adequate blood flow to the brain is necessary in the
course of general anesthesia in order to assure safe recovery and normal brain
function after surgical intervention. Brief episodes of hypotension have been
shown to cause acute brain damage in animal models. We used a rat
hemorrhagic shock model to assess functional outcome and to measure the
relative neuronal damage at 1, 4 and 14 days post-injury.
Methods:
250g to 350g Sprague-Dawley male rats were subjected to severe
hypotension induced by withdrawal of arterial blood from the right femoral artery,
while under Isoflurane anesthesia. The mean arterial blood pressure was
maintained between 20-30 mm Hg for one minute per hour, for a total of 3 times
per rat in a two hour period. Shed blood was immediately returned to venous
circulation, returning systemic pressure to normal. The rats were separated into 4
groups as follow: groups 1, 2 and 3 received 3 minutes of hypotension - 1 minute
every hour - and were evaluated at 1, 4 and 14 days, respectively. An additional
group of rats, group 4, received a sham operation. A neurological assessment
including motor abilities, sensory system evaluation and retrograde memory was
performed at 1, 4 and 14 days post-hypotensive insult. Brains were harvested
and stained for Fluorojade C and Nissl at 1, 4 or 14 days. Stereology was used to
analyze Fluorojade C and Nissl stained brain sections to quantitatively detect
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neuronal damage after the hypotensive insult. Statistical analysis was performed
using Graphpad Prism 5 with the Bonferroni test at a 95% confidence interval,
after ANOVA and for passive avoidance evaluation, Mixed Effect Model was
used.
Results:
We used a rat hemorrhagic shock model to assess behavior and
functional outcome and to quantify the relative neuronal damage at 1, 4 and 14
days post-hypotension. Significant differences in cell injury were seen between
control rats and rats that received 3 minutes of hypotension solely at one day
after the insult represented by numerous Fluorojade positive cell in the
hippocampus quantified by using stereology (optical dissector). Also, a
significant decrease in the number hippocampal cells was seen at day 14. No
changes in frontal cortical cells were evident at any time.
Discussion:
Our observations suggest that in this hemorrhagic model in SpragueDawley rats, even brief periods of hypotension result in cell damage. We did not
find any significant changes in behavior in this study,
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Introduction:
Maintenance of adequate blood flow to the brain is necessary in the course
of general anesthesia for all patients in order to assure safe recovery and normal
brain function after surgical intervention (1,2). Predictable models of neuronal
loss after progressive low blood pressure insults have been developed.
Yamauchi et al; have described selective progressive damage to regions of the
brain after 2, or 3 minute episodes of profound hypotension (low blood pressure,
25 mmHg) after one week of recovery (3,4). These changes were carefully
attributed to neuronal necrosis, or accidental cell death, measured one week
after all rats survived the hypotensive challenge. However, this study did not
measure functional behavior after recovery from hypotension.
Cognitive dysfunction has been linked with hypotension (5,6), especially in
elderly patients (7-9). Several studies have studied the relation between
hypotension during surgery and neurological performance after surgery but so far
a clear link has not been found (10). The largest study that evaluated this matter
was “The International Study of Postoperative Cognitive Dysfunction” but no
association between surgical blood pressure and postoperative cognitive function
was found (11). In contrast, other researchers have found a link between
postoperative cognitive function and blood pressure during surgery(12,13).
With this in mind we designed an animal study that was able to show a
clear link between blood pressure during surgery and long-term functional
alterations. The investigation of short bouts of hypotension with lack of brain
activity will provide evidence of the amount of brain damage caused at an
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extended two week period. It is likely that the damage can be more effectively
quantified with combined behavioral and tissue analysis at extended time points.
A secondary objective of this study is to characterize an animal model of
hypotension that would produce cerebral ischemia useful for testing of anesthetic
protection.
Materials and Methods.
Regulations:
The present study was presented, evaluated and approved by the division
of Comparative Medicine at the University of South Florida (USF). The
experiments were done in following the guidelines of the IACUC of the University
of South Florida’s College of Medicine.

Table 1. Study Design. The rats were separated into four groups as follows:
groups 1, 2 and 3 received 3 minutes of hypotension - 1 minute every hour and were evaluated at 1, 4 and 14 days, respectively. An additional group
of rats, group 4, received a sham operation.
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Table 2. Time course. Neurological assessment including motor abilities,
sensory system and retrograde memory were evaluated at 1, 4 and 14 days
post-hypotensive insult. Brains were harvested at 1, 4 or 14 days.

Animals:
Male Sprague Dawley rats from Harlan Laboratories (Indianapolis, IN),
with ages between 60 to 90 days and weights between 250 to 350 grams were
used for this experiment. Upon arrival to the USF College of Medicine Vivarium,
the rats were housed in a climate controlled room in plastic cages in groups of
two with free access to water and food and were left in quarantine for at least a
week before the experiment took place.
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Groups:
The animals were divided in 4 groups:
1. Control group; these animals received no hypotension.
2. These animals received 3 minutes of hypotension and were euthanized 24
hours after the surgery.
3. These animals received 3 minutes of hypotension and were euthanized 4 days
after the surgery.
4. These animals received 3 minutes of hypotension and were euthanized 14
days after the surgery.
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Neurological Assessment:
We used a forty-eight point neurological score to evaluate the animals
(14). The test was done at 2 different time points. The first evaluation was the
day before the surgery, this test was done to assure that neurologically the rats
were intact; having an animal with any kind of neurological deficit would prevent
the animal to be part of the study. No animals were withdrawn from the study
under those criteria. The second evaluation was before tissue collection. The
neurological scale is shown in Table 3.
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POINTS
TEST

Spontaneous activity

0

1
General status

Normal

Calm, quiet,

(5min)
Body symetry

Normal

explores slowly
Slight asymmetry

Gait (open bench top)

Normal

Stiff inflexible

2

3

4

Somnolent;

Stuporous; some No

minimal

movements in

spontaneous

exploration
Moderate
asymmetry
Limping

place
Prominent
asymmetry
Trembling,
drifting, falling

movement
Extreme
asymmetry
Does not walk

Simple motor
Front limb symetry

Normal

Circling/bench top

Not present

Circling/holding tail

Not present

Hind limb placement

Normal

Light asymmetry

Marked
Prominent
No body/limp
asymmetry
asymmetry
movement
Predominantly one Circles to one side Circles
Pivoting,
constantly to one swaying or no
sided turns
side
movement
Tendency to turn to Circles to one side Pivots to one
Does not
one side
side sluggishly advance
Slow placement
No placement
-

Complex motor
Vertical screen climbing

Normal

Beam walking

Walks to the
end of the
beam

Climbs with strains; Holds onto slope; Slide down slope Slides
immediately; no
limb weakness
does not slip or
effort to prevent
present
climb
fall
Walks to the middle No walking, stays Unsuccessful
Falls
effort to prevent
of the beam
more than 10 s
fall
immediately

Sensory
Fore limb touch (needle) Normal

Withdraws slowly

No withdrawal

Hind limb touch (needle) Normal

Withdraws slowly

No withdrawal

Trunk touch (needle)

Light asymmetry

Prominent

Vibrassae touch

Face touch (needle)

Symmetric

Symmetric

Normal

Light asymmetry

Withdraws slowly

asymmetry
Prominent

asymmetry
No withdrawal

-

-

Absent
ipsilateral and
diminished
contralateral
response
Absent
ipsilateral and
diminished
contralateral
response
-

Response
absent
bilaterally
Response
absent
bilaterally
-

Table 3. Fourty eight points neurological scale. This scale has been used in
previous papers and includes general status and motor and sensory
abilities (14).

We wanted to evaluate memory function; to achieve this we used the
passive avoidance paradigm. Habituation is the first step, the animal was placed
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on a platform in a plexiglass box and we measured the time they remained on
the platform before they step down of it. Next day is training day: we placed the
animal on the platform and once the animal had positioned the four limbs down
the platform it received an electric shock (0.5mA) for three seconds. The animal
learned that the safe place to be was the platform.
In this case we were testing retrograde memories so the animals were
trained before the surgery. On the day before tissue collection; the animal was
placed in the platform and we measured the time it took to step down the
platform up to a maximum of 5 minutes (300 seconds). Latencies greater than
300 seconds were assigned this value. Finally, on the euthanasia day we
measured the time the animal stayed on the platform up to 5 minutes.
Anesthesia:
After the weight was recorded, the animal was anesthetized in an
induction chamber with 5% Isoflurane in 100% Oxygen. After the rat was fully
anesthetized we changed the animal from the induction chamber to a mask with
1 to 2% Isoflurane in 100% oxygen. The rats were continuously anesthetized
during the three episodes of hypotension.
Surgery:
After shaving the neck, the area was cleaned with iodine and a medial
linear incision was made. Plastic catheters were inserted in the jugular vein and
both carotid arteries (bilateral). The arterial lines were used for blood pressure
quantification and blood aspiration; the venous line was used for blood
reinfusion. The blood was rapidly aspirated until the mean arterial pressure
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(MAP) reached a point below 20; if the animal did not reach a MAP below 20 at
any of the 3 episodes, it was excluded from the experiment.
When MAP was below 20, the chronometer was set for 60 seconds.
Between 8 cc to 15 cc of blood were taken to reach MAP of 20 or less. After the
minute, the blood was reinfused using the venous catheter. During the procedure
the animals were placed on a heated pad to prevent hypothermia. At the end of
the third hypotensive episode the catheters were removed and skin was closed
with a skin stapler. The rats recovered in a fresh cage.
Physiological parameters:
The following variables were measured: Weight, temperature measured
with a rectal thermometer (a heated pad was used to maintain body temperature
during the procedure); a pulse oximeter was used to measure hemoglobin
saturation (Hb Sat); heart rate (HR) and blood pressure (BP) were obtained
directly from an arterial catheter placed in the carotid artery (SurgiVet Advisor
Monitor. Model number 92V303100 was used for Hb Sat, HR and BP). Readings
were made before and after each ischemic event. Weight was measured right
before the surgery and at day 14.
Brain Extraction and Sectioning
The animals were euthanatized with an overdose of CO2; immediately
after the animal was perfused with normal saline solution 0.9% followed by 4%
paraformaldehyde. The brains were harvested, stored in plastic tubes with 4%
paraformaldehyde for 24 hours, and then changed to 10%, 20% and 30%
sucrose every 24 hours. Brains were then sectioned at 40µm with cryostat HM
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550 from MICROM International, the chamber temperature was turned down to
minus 22°C. A series of 5 coronal sections spaced approximately 960 microns
apart were stained. Fluorojade C and Nissl were used for histological analysis.
The sections were mounted for histopathology analysis and remaining sections
were stored in PBS plus Azide.
Fluoro Jade C:
Fluoro Jade C stain is commonly used in ischemia research to label
degenerating neurons regardless of the insult. Fluoro Jade C analysis was used
to quantify the number of degenerating cells in cortex and CA1 area of the
hippocampus; the method used is described in detail (15). The sections were
mounted on slides and air-dryed overnight. Then, dipped in absolute ethyl
alcohol 3 times, and 1 minute in 70% ethyl alcohol; washed in running tap water
1 minute. Stained with potassium permanganate to oxidize tissue for 15 min
while shaking gently. 120 mg of potassium permanganate (KMnO4) 0.06% was
diluted in 200 mL of PBS. At this point the slides were protected from light.
Staining with Fluoro Jade C 0.001% for 30 minutes was follow by 3 changes of
water for 1 minute and air dry overnight. The next day under the fume hood, clear
in xylene for 2 minutes, 3 times. Coverslipwith DPX directly from xylene. FluoroJade stock was made with 0.01% Fluoro Jade C in water (dilute 2 mg/ 20 ml).
The working solution was made with 0.001% Fluoro-Jade C in 0.1% acetic acid.
Dilute 20 ml stock with 180 mL of water plus 200 uL of acetic acid.

62

Nissl:
Nissl is a classic stain used for detection of Nissl bodies in the cytoplasm
of cells, which will be stained purple-blue. Sections were mounted and let air dry
on a slide warmer overnight. Next day they were dehydrated through 100% and
95 % alcohol to distilled water. After that were stained in 0.1% cresyl violet
solution for 5 minutes and then rinsed with distilled water.
Following they were immersed in 95% ethyl alcohol for 30 minutes and posterior
dehydrated in 100% alcohol 2 times for 5 minutes. Under the fume hood they
were cleared in xylene for 2 minutes, 3 times and then immediately coverslip with
DPX .
Statistical Analysis:
The data is presented as Mean ± SE. Counting of Fluoro Jade C positive
cells and Nissl cells was done using unbiased stereology (Optical fractionator) as
described in by Mouton (16). For this purpose the Stereologer from Stereology
Resource Center, Chester, Maryland was used. The results are an estimate of
the total number of cells. Neurological score data were also evaluated. One way
Analysis of Variance was follow by Bonferroni’s Multiple Comparison test. The
results were analyzed using GraphPad Prism 5.0 for Mac. Passive avoidance
was evaluated using Mixed Effect Model. p-value of <0.05 were considered
statistically significant.
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Results
We designed the experiment with 40 animals, 7 of them died during
surgery. 3 from the group that undergo euthanize at day 1, 2 animals belong to
the group that was euthanized at day 4 and 2 more from the group that was
euthanized at day 14. Necropsies showed that pulmonary embolism and
technical complications were the main culprits. 5 more animals died after
surgery; bleeding from the arterial incision and neurological deficits were the
cause; this included 2 animals in the group that was euthanized at day 4 and 3
animals in the group that was euthanized at day 14. Dead animals were not
replaced (See Table 4).
Physiological variables were considered. The results are shown in the
next figure. The mean arterial pressure combining all the groups before the first
insult was 100.3 + 42, 94.3 + 38 before the second insult and 102 + 40 before the
last insult. After the insult the mean arterial pressure was 87.7 + 56.2, 94.5 +
57.2 and 92.7 + 43.2 respectively. During the hypotension period, the blood was
withdrawn until the MAP reach 20 or less.
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Control
(n=10)

Euthanize day 1
(n=7)

Euthanize day 4
(n=6)

Euthanize day 14
(n=5)

Initial Weight (g)

333 + 18

352 ± 11

334 ± 12

344 ± 22

Final Weight (g)

370 + 20

349 ± 13

361 ± 29

380 ± 39

Initial T° (F°)

94.8 ± 2.2

93.02 ± 2.6

92.58 ± 4.3

Final T° (F°)

89.6 ± 7.5

91.88 ± 2.6

88.8 ± 3.1

First MAP

19 ± 2

20 ± 2

19 ± 2

Second MAP

19 ± 1

19 ± 1

20 ± 1

Third MAP

20 ± 2

18 ± 1

19 ± 1

Initial HR (bpm)

254 ± 43

271 ± 50

248 ± 61

Final HR (bpm)

267 ± 49

233 ± 59

250 ± 54

Initial Hb. Saturation

97 ± 2

94 ± 6

95 ± 4

Final Hb. Saturation

95 ± 5

94 ± 4

98 ± 7

Table 4. Physiological variables. Values are mean ± SD. MAP = Mean
Arterial Pressure, HR = Heart rate, To = Temperature, BPM = Bits Per
Minute, Hb = Hemoglobin, F°= Fahrenheit. No significant differences were
found.

We did not find any statistically significant differences between the preoperative values and the post-operative values. We also compared the weight
before the ischemic event and at day 14, and did not find any statistically
significant change.

65

Neurological performance was evaluated in all animals as shown in the
next figure (Neurological Scores). Behavior measurements on postoperative day
1, 4 and 14 were compared with control; at day one there were positive findings
(palpebral ptosis). These findings were not present at day 4 or 14. Although there
was neurological impairment 24 hours after the injury, statistically, these changes
were not significant (p > 0.05). It is important to mention that some animals also
showed some degree of paralysis right after the surgery but by the time of the
neurological evaluation it was no longer present.

Figure 1. Neurological Score. The figure show no significant changes in the
neurological score. The only change found at 24 hours was palpebral
ptosis in some animals, this finding was not present at day 4 or 14.

Passive avoidance as described by Saporta (17), was used to tested the
ability to recall old memories. During the habituation and training, animals
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learned to stay on the platform to avoid an electric shock. We confirmed learning
by measuring the time the rat stayed on the platform before hypotension and
later we retested the animals after hypotension.
We did not find any memory impairment in the animals after the surgery in
comparison with the control animals.
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Figure 2. Passive avoidance. None of the animals have any memory deficit
after the procedure at any of the check points.

Stereology was used to estimate the total number of positive Fluoro Jade
C cells in the frontal cortex and CA1 area of the hippocampus. No significant
differences in cell injury represented by numerous fluoro jade positive cortical
cells were seen between control rats and rats that received 3 minutes of
hypotension (p > 0.05)
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Effect of 3 minutes of hypotension in frontal cortex.

Figure 3. Effect of 3 minutes of hypotension in frontal cortex. Estimated
total number of Fluoro-Jade C positive cells in animals subject to 3 min of
hypotension.
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Figure 4. Pictures from frontal cortex. Fluoro jade C positive cells in
cortical areas in animals subject to 3 minutes of hypotension.

On the other hand significant differences in cell injury were seen between
control rats and rats that received 3 minutes of hypotension solely at one day
after the insult represented by numerous fluoro-jade C positive cells in the CA1
area of the hippocampus (p < 0.05). See Figure 5 and 6.

Figure 5. Effect of 3 minutes of hypotension in the CA1 area. Group 1 =
Stereology cell count in CA1 region, euthanize at day 1; Group 4 =
Stereology cell count in CA1 region, euthanize at day 4; Group 14 =
Stereology cell count in CA1 region, euthanize at day 14. There is a
statistically significant difference in between control and group 1.

.
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Figure 6. Pictures from CA1 area of the hippocampus. One day after injury
there are more fluoro jade positive cells than in the rest of the groups

We also counted Nissl cells in the frontal cortex and CA1 area of the
hippocampus and we found that the cortex was not statistically affected by the 3
episodes of 1 minute of hypotension at any of the 3 time points. In contrast, the
CA1 area of the hippocampus suffered a continuous decrease in the number of
cells statistically significant only at day 14 after the 3 non-consecutives minutes
of profound hypotension.
Results of the Nissl staining confirmed the findings of fluoro jade c; the
number of cells did not change in the frontal cortex but in the CA1 hippocampal
area there was a significant detriment in the number of cells evidenced two
weeks after the insult. The results from the Nissl cortical counting in the CA1
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area of the hippocampus are shown in figure 10 and 11 respectively. See Figures
7 and 8.

Figure7. Estimated total number of Nissl positive cells in frontal cortex.
There are no statistically significant differences between control and the
animals euthanized at day 1, day 4 and day 14.
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Figure 8. Estimated total number of Nissl cells two weeks after the insult in
the CA1 area of the hippocampus. At day 14 after the insult there is a
statistically significant difference in comparison with control.

The results in the CA1 area are congruent with the results found in the
Fluoro Jade C staining; Fluoro Jade C shows an increase in the number of cells
that suffered some degree of damage and in this case the day after the surgery
there was a significant increase of damaged cells. At day 14, as shown with the
Nissl stain, the cells that were injured at day 1 are gone and the number of
normal cells in the CA1 area is significantly lower.
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Discussion:
The present observations evidenced that repeated hypotensive episodes
lead to hippocampal damage, which may have clinical implications. Patients with
hemodynamic TIAs, cerebral arteriosclerotic disease, or orthostatic hypotension
may experience repeated nonfatal circulatory deficiencies. Our results suggest
that in this rat hemorrhagic model, brief periods of hypotension result in neuronal
damage or distress in the hippocampal CA1 region one day after insult. By day
14, surviving cells are significantly reduced in the hippocampus. We did not find
any significant changes in cortical cells.
We evaluated the changes in weight in all the groups and there was not a
significant change; we believe that although the animals showed some
histological changes in the CA1 area of the hippocampus the damage is not
enough to induce weight changes.
Hypothermia has also shown to reduce ischemic damage(18), to prevent a
hypothermic state in our animals a heated pad was placed underneath the rat
preventing the presence of variables of confusion. There were not significant
changes in the initial and final temperature. The mean initial temperature was
93.5 + 3 and the final was 90 + 4.4.
Between 8 cc to 12 cc of blood were taken each time to achieve a mean
arterial blood pressure below 20. The mean arterial blood pressure for all the
groups at the beginning of the hypotensive period was 19.2 + 1.1. Yamauchi
(3,4) found histopathological changes after one week; in the hippocampus with a
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MAP of 25 with 2 or 3 minutes of hypotension. In our hands these changes
continue to be present two week after the insult.
The forty-eight points neurological scale did not show any statistically
significant changes Interestingly we found temporal paralysis in the upper body
that lasted only few hours; by the time of the neurological evaluation the paralysis
was gone and could not be recorded as a positive finding. A common finding
after 24 hours of recovery was palpebral ptosis but statistically this finding was
not significant; in all the cases where palpebral ptosis was found, recovery was
complete by day 4. In humans the dissection of the Internal carotid artery,
typically manifests as an oculo-sympathetic palsy (myosis and palpebral
ptosis)(19), we placed the catheters in the common carotid artery but since the
surgical area is small, it is possible that we had manipulated the internal carotid
artery leading to this finding.
Passive avoidance paradigm has been used for memory evaluation;
Bekker et al. have demonstrated using this paradigm that hypotension can cause
disruption in consolidation of long term memory. In the present study we did not
find any memory alterations (20). We hypothesize that this difference is due to
either the type of hypotension; since they used nitroglycerine and we withdrawn
the blood. The other important difference is the time of hypotension; Bekker
caused the hypotension early after the learning; in fact the latest injection was
given 3 hours after the training. In our study we trained the animals 24 hours
before the surgery and tested 24 hours after the surgery giving them enough time
to consolidate their memories. This study demonstrated that although there is
75

damage in the hippocampus after 3 separate periods of profound hypotension,
memories that are already consolidated were not affected.
Fluoro Jade C stain is a fluorescein derived used to label degenerating
neurons. We used this staining to evaluate brains on 1, 4 and 14 days after
hypotension. In a pilot study we evaluated the fluoro jade c stained brains; the
samples were viewed with a fully automated, upright Zeiss Axio- ImagerZ.1
microscope (Carl Zeiss Inc., Germany) with a 20x /0.5NA objective and a FITC
filter cubes. Images were produced using the AxioCam MRm CCD camera and
Axiovision version 4.6 software suite (Carl Zeiss Inc., Germany). The resulting
images were analyzed for number and intensity of degenerative neurons using
Image Pro Plus 6.2 (Media Cybernetics Inc., Silver Springs, Maryland). We used
the confocal microscope to have a better visualization and also to take pictures.
Samples were viewed with a Leica DMI6000 inverted microscope, TCS SP5
confocal scanner, and a 40X/1.30NA Plan Apochromat oil immersion objective
(Leica Microsystems, Germany). An argon laser line was applied to excite the
samples and tunable filters were used to minimize background fluorescence.
Image were captured with photomultiplier detectors and prepared with the LAS
AF software version 1.6.0 build 1016 (Leica Microsystems, Germany). At this
point we found a significant difference in the in the number of fluoro jade c
positive cells in the frontal cortex at day 1(21), however this significant difference
was not evident when stereology was used. Results found in Fluoro jade c cells
at day one in the CA1 hippocampal area were significant with the two methods.
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We concluded that one day after repetitive periods of hypotension there is brain
damage that can persist after 2 weeks.
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Abstract:
Introduction:
Previous studies in our lab have demonstrated that short periods of
hypotension can cause histological changes in the hippocampal CA1 area, while
behavior remains unchanged (1). We believe that an even stronger insult may
also cause behavioral changes. We used a rat hemorrhagic shock model plus
temporary hypoxia to assess functional outcome at different time points postinjury.

Methods:
Sprague-Dawley rats were subjected to brief, severe hypotension induced
by withdrawal of arterial blood from the right femoral artery. Mean arterial blood
pressure was reduced to 20 to 30 mm Hg for three consecutive minutes, while
the animal was breathing 12% O2 in N2. Mean Hb saturation was maintained at
74.2%. After the 3 minutes shed blood was immediately returned to venous
circulation, returning systemic pressure to normal. At the end of the hypotensive
period the animals were returned to breathing air. Animals were evaluated at
different time points before their brains were harvested for quantitative histology.
Group 1: Control, normal animals with no injury. Neurological evaluation at day
0, 1, 4 and 14, passive avoidance at day 3, 4, 7 and 14, euthanized at day 14.
Group 2 received hypotension plus hypoxia: Neurological evaluation before the
surgery and at day 1, euthanized at day 1; Group 3 received hypotension plus
hypoxia: Neurological evaluation before the surgery and at day 4, euthanized at
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day 4; and Group 4 received hypotension plus hypoxia: neurological evaluation
at day 0, 1, 4 and 14, passive avoidance at day 3, 4, 7 and 14, euthanized at day
14. Group 5 received hypotension plus hypoxia and was treated with isoflurane
per 90 minutes after the insult: neurological evaluation at day 0, 1, 4 and 14,
passive avoidance at day 3, 4, 7 and 14, euthanized at day 14.
We used a 48 point neurological evaluation scale, in which the higher the
number the worse the deficit (2). Histopatologycal analysis with NeuN and Nissl
was performed. Statistical evaluation with ANOVA followed by Bonferroni test for
NeuN and Nissl results; for neurological evaluation we used Dunnett’s multiple
comparison test after ANOVA and for passive avoidance a Mixed Effect Model
was used. Significance was defined as p < 0.05.

Results:
Neurological assessment showed that hypotension plus hypoxia resulted
only in little abnormalities, but no statistically significant changes were found. In
the passive avoidance test we found that new memories were still created after
the injuries but animals with no hypotension/hypoxia had a better performance in
comparison with the hypotension/hypoxia. The use of isoflurane 90 minutes after
the insult showed to protect the animals from memory alterations. No
histopatological changes were found in any of the groups.
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Discussion:
This observation suggests that in this model of hypotension plus hypoxia
there is mild cerebral damage that is reflected by memory changes and this
deficit is maintained two weeks after the insult. Exposure to isoflurane after the
insult can prevent the onset of memory deficits.
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Introduction:
Recent publications have shown that hypotension during surgery can
produce a range of effects from post operative memory deficits (3) to an increase
in mortality during the next year after surgery; specially in elderly patients (4).
Permanent, stable and adequate blood flow to the brain is necessary during
general anesthesia in order to assure safe recovery and normal brain function
after a surgical intervention(5,6).
Some researchers have demonstrated that hypotension can have
deleterious effects in brain histology. Yamauchi et al; described progressive
damage to several regions of the brain after three separated 1-minute episodes
of hypotension (Mean Arterial Pressure 25 mmHg) after seven days of recovery
in rats (7,8). Although Post Operative Cognitive Dysfunction (POCD) does not
have a clear etiology, some physicians believe Intra Operative Hypotension
(IOH) may be the culprit (9,10). Schutz et al; found that a 30 minute period of
hypotension does not have any effect in structural and motor deficits but has
some effects in recovering cognition (11). Hypertensive patients seem to be more
sensitive to IOH, Yocum et al; has found a clear relation between IOH in
hypertensive patients and decline in cognitive function (12). Patients with
advanced age seem to be more vulnerable to POCD after IOH (13-15) but not all
the studies have shown a clear relation between IOH and POCD (16,17).
In our laboratory, using a rat model of hypotension, we have found a clear
relation between IOH and histological changes in the hippocampus but not the
cortex and memory was not affected (1).
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Animal models of hypotension and hypotension plus hypoxia are necessary
to study the effect of these variables and their effects in the central nervous
system. In this study we evaluated the effect of a short period of profound
hypotension plus hypoxia. Histology and behavioral testing was used in order to
clearly understand the relation between these variables.
Materials and Methods.
Regulations:
The present study was presented, evaluated and approved by the division
of Comparative Medicine at the University of South Florida (USF). The
experiments were done in following the guidelines of the IACUC of the University
of South Florida’s College of Medicine.
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Table 1. Study design. The rats were separated into five groups as follows;
group 1 was the control (no injury), the other 4 groups received 3
consecutives minutes of hypotension plus hypoxia and were euthanized at
day 1, 4 or 14; the last group received treatment with isoflurane per 90
minutes.
Five groups were used in this study; the first 4 groups shown were design
to characterize the damage caused by hypotension plus hypoxia and the
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isoflurane group was added to determine if the expected damage could be
reversed with this anesthetic.
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Table 2. Time course. Neurological evaluation and memory test were used
to evaluate the damage caused by hypotension plus hypoxia.
The creation of new memories after the insult were evaluated using the
passive avoidance paradigm as described by Saporta (18). A fourty eight point
scale was used for neurological assessment at different time points in a two
week period (2).
Animals:
Male Sprague Dawley rats from Harlan Laboratories (Indianapolis, IN),
with ages between 60 to 90 days and weights between 250 to 350 grams were
used for this experiment. Upon arrival to the USF College of Medicine Vivarium,
the rats were housed in a climate controlled room in plastic cages in groups of
two with free access to water and food and were left in quarantine for at least a
week before the experiment took place.
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Groups:
The animals were divided in 5 groups:
1. Control group, these animals received no hypotension.
2. These animals received 3 minutes of hypotension plus hypoxia and were
euthanized 24 hours after the surgery.
3. These animals received 3 minutes of hypotension plus hypoxia and were
euthanized 4 days after the surgery.
4. These animals received 3 minutes of hypotension plus hypoxia and were
euthanized 14 days after the surgery.
5. These animals received 3 minutes of hypotension plus hypoxia, they also
received treatment with isoflurane per 90 minutes after the insult and were
euthanized 14 days after the surgery.
Neurological Assessment:
Neurological evaluation was performed twice in every animal. The first
evaluation was the day before the surgery, this test was done to assure that
neurologically the rats were intact; having an animal with any kind of neurological
deficit would prevent it to be part of the study. No animals were withdrawn from
the study for this reason. The second one was done before tissue collection. We
used a forty-eight point neurological score to evaluate the animals. This scale
was taken Yokoo et al, it is the result of combining elements of several systems;
0 points indicate normal function, a total of 48 deficit point is possible (2). See
Table 3.
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POINTS
TEST

Spontaneous activity

0

Normal

1
General status
Calm, quiet,

(5min)
Body symetry

Normal

explores slowly
Slight asymmetry

Gait (open bench top)

Normal

Stiff inflexible

2

3

4

Somnolent;

Stuporous; some No

minimal

movements in

spontaneous

exploration
Moderate
asymmetry
Limping

place
Prominent
asymmetry
Trembling,
drifting, falling

movement
Extreme
asymmetry
Does not walk

Simple motor
Front limb symetry

Normal

Circling/bench top

Not present

Circling/holding tail

Not present

Hind limb placement

Normal

Light asymmetry

Marked
Prominent
No body/limp
asymmetry
asymmetry
movement
Predominantly one Circles to one side Circles
Pivoting,
constantly to one swaying or no
sided turns
side
movement
Tendency to turn to Circles to one side Pivots to one
Does not
one side
side sluggishly advance
Slow placement
No placement
-

Complex motor
Vertical screen climbing

Normal

Beam walking

Walks to the
end of the
beam

Climbs with strains; Holds onto slope; Slide down slope Slides
immediately; no
limb weakness
does not slip or
effort to prevent
present
climb
fall
Walks to the middle No walking, stays Unsuccessful
Falls
effort to prevent
of the beam
more than 10 s
fall
immediately

Sensory
Fore limb touch (needle) Normal

Withdraws slowly

No withdrawal

Hind limb touch (needle) Normal

Withdraws slowly

No withdrawal

Trunk touch (needle)

Light asymmetry

Prominent

Vibrassae touch

Face touch (needle)

Symmetric

Symmetric

Normal

Light asymmetry

Withdraws slowly

asymmetry
Prominent

asymmetry
No withdrawal

-

-

Absent
ipsilateral and
diminished
contralateral
response
Absent
ipsilateral and
diminished
contralateral
response
-

Response
absent
bilaterally
Response
absent
bilaterally
-

Table 3. Fourty-eight points neurological score. This scale includes general
conditions, motor and sensory abilities giving a complete assessment of
the neurological status of the animal.

96

Passive Avoidance:
Memory was assessed using the passive avoidance paradigm (PA);
habituation, training and testing were done after the hypotensive/hypoxic insult.
Habituation occurred 24 hours after surgery: during habituation the animal was
placed in a plexiglass box, the floor of the cage is an exposed metallic grid that
can be manually electrified; on habituation day the animal is placed on a platform
that prevent the animal from touching the grid and animals tend to spontaneously
step down the platform and the latency is recorded. On the next day the grid is
electrified with 0.5mA and again we measured the time they remained in the
platform before they step down of it; once the animal have placed the four limbs
down the platform, the animal received an electric shock (0.5mA) for three
seconds. If memory process is intact the animal learns that the safe place to be
is the platform. A day 3, 4, 7 and 14 we placed the animals on the platform and
measured the time the animal took to step down of it, with a maximum of 5
minutes (300 seconds). Latencies greater than 300 seconds were assigned this
value. Finally on tissue collection day we took the time the animal remained on
the platform up to 5 minutes. P.A. was only measured in the control group and
the group euthanized at day 14 (18).
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Anesthesia:
After the weight was recorded, the animal was anesthetized in an
induction chamber with 5% isoflurane in 100% oxygen. After the rat was fully
anesthetized we changed the animal from the induction chamber to a mask with
1 to 2% isoflurane in 100% oxygen. Animals remained anesthetized at all times.
Animals in the isoflurane group received 1% isoflurane in 100% oxygen by mask
for 90 minutes after the insult.
Surgery:
After shaving the neck, the area was cleaned with iodine and a medial
linear incision was made. Plastic catheters were inserted in the jugular vein and
both carotid arteries (bilateral). Arterial lines were used for blood pressure and
blood suction; the venous line was used for blood reinfusion. Blood was
aspirated until the mean arterial pressure (MAP) reached a point below 30.
Hypoxia was induced with a mixture of 12% oxygen and 88% nitrogen, the
animal breathed the mixture for 5 minutes before the hypotensive period and
during the hypotensive period. As soon as MAP was below 30, the chronometer
was set for 180 seconds. Between 8 cc to 15 cc of blood were taken to reach the
MAP of 30 or less. After the hypotensive episode, the blood was reinfused using
the venous catheter, and the hypoxic mixture was stopped and 100% Oxygen
was given to the animal until the end of the surgery. The catheters were removed
and the wound closed with a skin stapler. During the procedure the animals were
placed on a heated pad to prevent hypothermia. Recovery from procedure was in
a fresh cage.
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Physiological parameters:
Physiological parameters were measured to assure that the results we
obtained due to the insult and could not related to alterations in physiologic
changes. The variables we measured were: Weight, temperature taken with a
rectal thermometer (a heated pad was used to maintain body temperature during
the procedure), hemoglobin saturation with a pulse-oximeter (Hb Sat), finally
heart rate (HR) and blood pressure (BP) were taken directly (SurgiVet Advisor
Monitor. Model number 92V303100 was used for Hb Sat, HR and BP). Readings
were taken before, during and after the ischemic event. Weight was measured
before the surgery and at day 14.
Brain Extraction and Sectioning
The animals were euthanatized with an overdose of CO2, immediately
after, the animal was perfused with normal saline solution 0.9% followed by 4%
paraformaldehyde. The brains were harvested, stored in plastic tubes with 4%
paraformaldehyde for 24 hours, and then changed to 10%, 20% and 30%
sucrose every 24 hours. Brains were then sectioned at 40µm with cryostat HM
550 from MICROM International, the chamber temperature was turned down to
minus 22°C. A series of 5 sections spaced approximately 960 microns apart were
stained. NeuN and Nissl stains were used for histological analysis. Sections were
mounted for histopathology analysis and the remaining sections were stored in
PBS plus Azide.
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NeuN:
NeuN (Neuronal Nuclei) is used to label alive neurons. Immunoreactivity is
observed after mitosis. NeuN is primarily localized in the neuronal nuclei with
lighter staining in the cytoplasm. The staining was done following the instructions
from the manufacturer (Chemicon).
Nissl:
Nissl is used for detection of Nissl bodies in the cytoplasm of Cells. The
Nissl body stain purple-blue. We used this staining to count the number of cells in
the Hippocampus.
Statistical Analysis:
Data is presented as Mean ± SE. To count the number of NeuN positive
cells and Nissl cells in we used unbiased stereology (Optical fractionator) as
described in other publications (19-21). For this purpose the Stereologer from
Stereology Resource Center, Chester, Maryland was used. The results are an
estimate of the total number of cells. Neurological score and passive avoidance
data were also evaluated. The results were analyzed using GraphPad Prism 5.0
for Mac. One way Analysis of Variance was used followed by Bonferroni’s
Multiple Comparison Test for NeuN and Nissl. For neurological evaluation we
used Dunnett’s multiple comparison test after ANOVA. Passive avoidance was
analyzed using the Mixed Effect Model to study the general differences between
groups during the two week period; for specific time points we used One way
Analysis of Variance followed by Bonferroni’s Multiple Comparison Test. p-value
of <0.05 were considered statistically significant.
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Results
We designed the experiment with 50 animals, 10 of them died during or
after surgery (2 per group). Necropsies showed that pulmonary embolism,
bleeding from the arterial incision and neurological deficits were the cause, these
animals were not replaced and the experiment was completed with the remaining
animals.
Physiological variables are presented on Table 4. The mean arterial
pressure combining all the injured groups before the insult was 110, during the
insult the mean arterial pressure was 27 and after the blood was reinfused the
MAP was 87. We did not find any statistically significant differences between the
pre-operative values and the post-operative values. Normal animals with no
injury, gained an average of 24 grams in two weeks, the animals that received
the insult gained an average of 25 grams in the same period; the animals that
received the insult plus were treated with isoflurane 90 minutes after the insult,
gained 8 grams in average. Statistically we did not find any significant difference.
The animals that received the insult have lower weight at day 1 and 4 after the
injury but by day 14 the weight was comparable with the control animals. The
mean hemoglobin saturation during the episode measured immediately before
the hypotensive insult was 74.2; the values before and after the insult were 94.8
and 95.5 respectively. No significant changes in temperature and heart rate were
found.

101

Table 4. Values are mean ± SD. MAP = Mean Arterial Pressure, HR = Heart
rate, To = Temperature, bpm = Bits Per Minute, Hb = Hemoglobin, F°=
Fahrenheit.
Neurological performance was evaluated in all animals and assigned a value in a
neurological score, see Figure 1. Behavior measurements on postoperative day
1, 4 and 14 were evaluated; the groups evaluated were: in group 1 are all the
animals with the sham surgery that received no insult; in group 2 we have the
animals that received the insult and were euthanized at day 14 and group 3 is the
group that received the insult and also were treated with isoflurane 90 minutes.
No statistically significant changes were found. (p > 0.05). It is important to
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mention that some animals also showed some degree of paralysis after the
surgery but by the time of the neurological evaluation it was no longer present.

Neurological score

2.0
1.5
1.0
0.5
0.0
1

2

3

Day 0

1

2

3

Day 1

1

2

3

Day 4

1

2

3

Day 14

GROUPS
1. Sham: No Hypotension/Hypoxia
2. Control: Hypotension/Hypoxia
3. Hypotension/Hypoxia. Treatment with Isoflurane.
Figure 1. Neurological score. The figure shows small and non-significant
changes in the neurological score. Only the groups euthanized at day 14
were subject of neurological evaluation.

Passive avoidance as described by Saporta (18), was used to tested the
ability to recall new memories. There was a statistically significant difference in
memory during the two week period this difference was more evident at day 7
and persisted at day 14 demonstrating that profound hypotension plus hypoxia
for short periods of time can impair the creation of new memories. Animals
treated with isoflurane after the insult did no show any memory impairment.
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Time in seconds
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*
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4
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2
y
da

da

y

1

0

Days after hypotension + hypoxia

GROUPS
1. Sham: No Hypotension/Hypoxia
2. Control: Hypotension/Hypoxia
3. Hypotension/Hypoxia. Treatment with Isoflurane.

Figure 2. Passive avoidance. There is a statistically significant difference
between groups 1 and 2 and 2 and 3. There is no statistically significant
difference between groups 1 and 3.

Stereology was used to estimate the total number of positive NeuN cells in
the CA1 area of the hippocampus. No difference in cell numbers were seen
between control rats and rats that received 3 minutes of profound hypotension
plus hypoxia at any time point (p > 0.05).
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Figure 3. NeuN positive cells in animals subject to 3 min of
hypotension/hypoxia. No statistically significant changes were found.
Similar number of cells were found at all the time points analyzed.

Nissl stained cells in the CA1 area of the hippocampus were counted and
although we found a pattern of decrease in the number of cells (see day 14) ,
there were no statistically significant changes at any time point after the
hypotension plus hypoxia insult.
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Figure 4. Nissl cells in CA1 area two weeks after the insult. No significant
changes in the number of cells in the CA1 area of the hippocampus were
found.
Discussion:
Although this model of insult is a temporary model (3 minutes of
hypotension plus 8 minutes of hypoxia), we occluded the two common carotid
arteries making it a model of constant hypoperfusion or global ischemia.
However, even with this permanent ischemia, we did not find changes in the CA1
area.
Weight is always a good indicative of general conditions, normal animals
increase in weight day after day; animals that received the insult lost a
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statistically significant amount of weight after the insult but by day 14 this
difference vanish among the groups.
Oxygen saturation was recorded with a pulse-oximeter and maintained at
an average of 74.2 + 6.6 assuring that although we used a facial mask for
administration the mixture of 12% oxygen plus 88% nitrogen was effective in
diminishing the saturation levels.
Between 8 to 15 milliliters of blood were taken from the animal to
decrease the blood pressure to a mean of 27.1 + 5.4. In previous experiments we
have used lower MAP (below 20) (22) but in a preliminary study using that
hypotension plus hypoxia the mortality was too high, for this reason we
maintained a higher MAP (MAP < 30).
Temperature is a well known factor in neuroprotection, the results showed
that the heated pad is a good device to control this variable. The temperature at
the beginning of the surgery was 95.5 + 2.9 and 93.5 + 1.6 at the end of the
surgery.
Neurological scale evaluation showed some negative effects related to the
procedure but statistically results were not significant. Palpebral ptosis was the
main motor alteration we found. In humans the dissection of the Internal carotid
artery, typically manifests as an oculo-sympathetic palsy (myosis and palpebral
ptosis)(23).
Passive avoidance was used to test anterograde memories and a
negative effect was seen one week after the insult, this memory deficiency
persisted at two weeks after the insult. In a recent paper Bekker et al; found
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impairment after hypotension in long term associative memory (3). Although we
did not use the same model of hypotension and we also added hypoxia, the
present study may highlight a similar mechanism. This memory deficit was
reverse by the use of isoflurane per 90 minutes after the insult.
Shutz et al; have demonstrated that hemorrhagic hypotension does not
cause structural damages but can cause cognitive alterations (11). Our study
showed a similar result, we found long-term (2 weeks) memory impairment
without neurological changes or histological changes in the hippocampus.
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CONCLUSIONS:
Ischemia seems to be the cause of several disabilities and even death
after surgical procedures. In the quest for options to manage it several variables
have been studied with mixed results. Among them are hypothermia,
hyperthermia, hyperoxemia, hyperglycemia, hyperventilation, etc.
Pharmacological agents have been used for these purposes in animals and in
humans with better results in the animals. Under specific conditions anesthetics
have shown to have a neuroprotective effect but they do not work equally well in
different models of ischemia (1).
The main objective of this research project was to test the neuroprotective
effect of anesthetics in different models of cerebral ischemia. The results of our
first study indicate that the combination of Isoflurane plus repeated administration
of a caspase 3 inhibitor (Z-DEVD-FMK) reduces the infarct size. We also
observed a clear pattern of improvement with the use of Propofol in combination
with Z-DEVD-FMK but it was not statistically significant. A similar but weaker
protective pattern was found with the use of the caspase inhibitor by itself but the
difference was not significant either. It is possible that by using a bigger sample
size these patterns could reach significance.
It seems clear that in a model of focal ischemia combined with mild global
ischemia (middle cerebral artery occlusion plus common carotid artery occlusion)
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the combination of volatile anesthetics with other pharmacological agents like
caspase inhibitors is necessary to achieve a sustained protection (two weeks)
(2). The positive results found with Isoflurane plus Z-DEVD-FMK confirmed that
the apoptotic cascade is activated during the ischemic event and interventions
directed to block apoptosis are possible targets of pharmacologic agents.
The synergistic effect of anesthetics plus caspase inhibitors has been
demonstrated by other researchers (3,4), and our results confirmed the
effectiveness of the combination.
Although the administration of Z-DEVD-FMK was done intraperitoneally
the caspase inhibitor reached intracerebral targets. We believe that the caspase
inhibitor got access to the apoptotic neurons thanks to the disruption of the
blood-brain barrier due to the ischemic insult.
We found a significant decrease in the number of Tunel positive cells in
the brains of the animals that received the caspase inhibitor and in order to
confirm that this effect was related to the intraperitoneal administration of the
caspase inhibitor, we counted the cells that were positive for cleaved caspase 3.
These results were consistent with the Tunel results and showed that animals
that received the intraperitoneal injection had an important decrease in the
number of apoptotic cells. We demonstrated that systemic administration of the
caspase inhibitors is effective and can be used for the treatment of ischemic
events in animal models.
Histological improvement was consistent with neurological performance at
four days after the insult; animals treated with anesthetics plus Z-DEVD-FMK
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showed a significant improvement in comparison with the animals that did not
receive the combination. By day 14 all the animals showed an important
improvement. We believe that the scale used was not sensitive enough to pick
some of the alterations that were present at two weeks after the insult. A more
comprehensive scale is necessary to have a better understanding of the
neurological outcome: for this reason, recently a 48 point scale was developed
by connecting together several neurological scales making a more specific and
reliable scale to measure neurological performance (5).
It is clear now that anesthetics alone can also be protective and that this
protection is sustained for long periods of time in models of focal ischemia(6).
Protection is evident in models of global ischemia only for short periods of
time(7). Since we occluded the middle cerebral artery and also the common
carotid artery, we created a mixed model of focal and global ischemia;
furthermore, the fact that anesthetics alone did not work could be explained for
the global ischemic effect created by the blockage of the common carotid artery.
In addition, it is also known that Isoflurane activates caspase 3 (8) and this is
probably at least part of the reason for the lack of effectiveness of Isoflurane in
models of global ischemia.
In our work we used a caspase 3 inhibitor because it is part of the
common pathway in the apoptotic cascade, and we believe that blocking only the
intrinsic or extrinsic apoptotic pathway is less effective than blocking the common
pathway. In addition, the caspase 3 inhibitor can also block the caspase 3
activating effect of the Isoflurane granting a more potent neuroprotection.
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In the bibliography, hypothermia has been reported to be an important
neuroprotective influence(1). In our study we controlled temperature to prevent
bias. To prevent a hypothermic state in our animals a heated pad was placed
underneath the rat. There were not significant changes in the initial and final
temperature. The mean initial body temperature was 93.5 + 3 and the final was
90 + 4.4. Although the temperature was lower than the normal, there are no
statically significant differences in between the groups. We are confident that the
results we obtained were not influenced by hypothermia since all the groups
showed similar values.
Monitoring other parameters like arterial blood gases and glycemia was
also important. We did not control these variables because of technical difficulties
but it is highly recommended to consider these parameters to be able to attribute
the results to the actual treatment been evaluated and not to external factors that
were not considered in the study.
In our experiments after collecting the brains we reviewed the placement
of the filament in the middle cerebral artery. We found that in a few cases the
filament moved. Therefore, we consider that, the filament approach to occlusion
of the middle cerebral artery is better for temporary focal ischemia rather than
permanent ischemia. For permanent blockage of the middle cerebral artery the
use of craniotomy and direct cauterization of the artery is recommended. This
allows the surgeon to insure that the artery will remain closed and permanent
focal ischemia will follow.
After finding the neuroprotective effect of anesthetics in combination with
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caspase inhibitors in the previous animal model, we decided to look for another
model of ischemia to verify the neuroprotective effect of anesthetics. We found
that anesthesiologists were divided regarding the issue of continuous monitoring
of arterial blood pressure during surgery. The group in favor of direct arterial
pressure monitoring believe that even a short period of hypotension not detected
by traditional monitoring methods, can be the origin of conditions like post
operative cognitive dysfunction. With that idea in mind we decided to study a
model of profound hypotension for short periods of time.
Initially the use of nitroprusside seemed to be the logical as the
hypotensive agent. However, after a pilot study with mixed results and
uncertainty whether the results were related to hypotension or the cyanide
released as a principal metabolite of nitroprusside; we opted for a bleeding
induced hypotension model. In a pilot study we tested one, two and three
minutes of profound hypotension (Mean Arterial Blood Pressure below 20) and
we did not find any changes either in the cortex nor in the hippocampus with only
one or two minutes of hypotension. In the three minutes of hypotension group,
we found fluoro jade C positives cells in cortex and hippocampus. Because of
these findings we decided to conduct a study to detect if those changes were
maintained.
Our observations evidenced that repeated hypotensive episodes lead to
hippocampal damage. Our results suggest that in this rat hemorrhagic model,
brief periods of hypotension result in neuronal damage in the hippocampal CA1
region one day after the insult. By day 14, surviving cells are significantly
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reduced in number in the hippocampus. We did not find any significant changes
in cortical cell numbers. We believe that more studies are necessary to elucidate
subtler effects of apparently innocuous periods of hypotension may not be
accurately detected by indirect blood pressure monitoring.
We evaluated the changes in weight in all the groups and there was not a
significant change. We believe that although the animals showed some
histological changes in the CA1 area of the hippocampus the damage was not
sufficient to induce weight changes two weeks after the injury. Although short
periods of profound hypotension may not alter general conditions, they can be
implicated in damage to very sensitive cells. More research is necessary to show
whether those changes are limited to the brain or if other organs are affected.
In our experimental model 8 cc to 12 cc of blood were removed each time
to achieve a mean arterial blood pressure below 20. The mean arterial blood
pressure for all the groups at the beginning of the hypotensive period was 19.2 +
1.1. Yamauchi, et al (9,10) found histopathological changes after one week in the
hippocampus with a MAP of 25 with 2 or 3 minutes of hypotension. In our
experience these changes continue to be present two weeks after the insult. Our
findings support previous data that showed deleterious effects of short periods of
hypotension. We found damages in the hippocampus and since this structure is
part of the machinery involved in creating memories, there is a possibility that
short periods of hypotension could explain cognitive impairment seen after
surgery in some patients.
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The forty-eight point neurological scale did not show any statistically
significant changes. Interestingly we found temporal motor paralysis in the upper
body that lasted only few hours. By the time of the neurological evaluation, the
paralysis was gone and could not be recorded as a positive finding. A common
finding after 24 hours of recovery was palpebral ptosis but statistically this finding
was not significant. In all the cases where palpebral ptosis was found, recovery
was complete by day 4. In humans the dissection of the Internal carotid artery,
typically manifests as an oculo-sympathetic palsy (myosis and palpebral
ptosis)(11), we placed the catheters in the common carotid artery but since the
surgical area is small, it is possible that we had manipulated the internal carotid
artery leading to this finding.
The passive avoidance paradigm is used for memory evaluation (12);
Bekker et al. (2009) have demonstrated using this paradigm that hypotension
can cause disruption in consolidation of long term memory (13). In the present
study we did not find any memory alterations. We hypothesize that this difference
is due to either the type of hypotension (they used nitroglycerine and we
withdrew the blood) or the other important difference is the timeline of the
hypotensive period. Bekker caused the hypotension early after the learning; in
fact the latest injection was given 3 hours after the training. In our study we
trained the animals 24 hours before the surgery and tested 24 hours after the
surgery giving them enough time to consolidate their memories. Our study
demonstrated that although there is damage in the hippocampus after 3 separate
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periods of profound hypotension, memories that are already consolidated were
not affected.
We used fluoro jade C to evaluate brains on 1, 4 and 14 days after
hypotension. We found a significant difference in the in the number of fluoro jade
c positive cells in the frontal cortex at day 1. Cells were counted using an
automatic method as previously described (14). However this significant
difference was not evident when stereology was used. Results found in Fluoro
jade c cells at day one in the CA1 hippocampal area were significant with the two
methods. We concluded that one day after repetitive periods of hypotension
there is brain damage that can persist after 2 weeks. Although the number of
affected cells in cortex did not reach significance, we believe that the presence of
these fluoro jade positive cells is important and should be considered; since the
numbers were close to significant and is possible that by using more animals
numbers can reach significance.
After finishing with this experiment we believed that although there was
some degree of damage, it was possible that the model was not severe enough
to test the efficacy of anesthetics as neuroprotective agents. For this reason we
decided to conduct another study with a stronger insult in order to create more
damage and in this way be able to test the effect of anesthetics in a new model.
We developed a model of profound hypotension similar to the one previously
used; but instead of using one minute every hour during two hours for a total of
three episodes of hypotension, we used three consecutive minutes of
hypotension combined with eight minutes of hypoxia. After the insult we exposed
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the animals to Isoflurane for ninety minutes to evaluate its effect.
We believed that because the insult was longer, the damage should be
greater, we were surprised we did not find any histological damage at any of the
time points analyzed (1 day, 4 days and 14 days). The histology was done using
NeuN staining. NeuN was used because it is specific for neurons and should
improve the counting methods. When we realized that no changes were found
and taking into consideration that in the previous study we had found changes
with the Nissl staining, we decided to confirm our NeuN results with Nissl
staining. Again no changes were seen. It is important to mention that we also
stained the brains with fluoro jade C only in the animals that were sacrificed at
day one and compared those results with control animals to see if any damage
was evident, but again no changes were seen. We did not show the fluoro jade c
results in here because not all groups were represented. Our theory is that to be
able to cause some damage in the brain it is necessary to have repetitive insults;
one insult was not capable of causing histological changes.
A closer look at the data shows that in this experiment we did achieve a
mean arterial pressure (MAP) below 20 as used in our previous study and as
used by other researchers (14). In a preliminary study using hypotension with a
mean arterial pressure below 20 plus hypoxia, the mortality was too high (80%),
for this reason we maintained a higher MAP (MAP < 30). It is possible that this is
a determining factor that can be responsible for the unexpected results.
The neurological scale showed some impairments related to the
procedure but statistically the results were not significant. This is not surprising
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since histological evaluation of one of the most ischemia sensible areas of the
brain was not affected. Palpebral ptosis was the main motor alteration we found;
again possibly related to the dissection of the Internal carotid artery, which
manifests as an oculo-sympathetic palsy in humans (myosis and palpebral
ptosis)(11).
Passive avoidance was used to test anterograde memories and a
negative effect was seen. In a recent paper Bekker et al (2009); found
impairment after hypotension in long term associative memory (13). Although we
did not use the same model of hypotension and we also added hypoxia, the
present study may highlight a similar mechanism. Other investigations have
demonstrated that hemorrhagic hypotension does not cause structural damages
but can cause cognitive alterations (15). Our study showed a similar result, we
found long-term (2 weeks) memory impairment without neurological changes or
histological changes in the hippocampus. What we find interesting is the fact that
using Isoflurane for 90 minutes after the insult could reverse the memory
changes seen with a single episode of hypotension plus hypoxia.
We concluded that a single episode of hypotension and hypoxia is not
enough to cause histological changes in the CA1 hippocampal area but it is
enough to cause memory changes that can be reversed with the use of
isoflurane.
As a general conclusion we demonstrated that anesthetics have a
neuroprotective effect. They act in different ways accordingly to the insult that
caused the injury and in some cases they need coadjuvants to exert its beneficial
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effect. In the first experiment, neither isoflurane and propofol showed any long
lasting protective effect by themselves, nor the coadjuvant drug alone, but the
combination was neuroprotective. In the second case although there were not
histological changes there were memory changes that were prevented by the use
of only anesthetics.
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